Pubblicazioni

Assessing 'no evidence of disease activity' status in patients with relapsing-remitting multiple sclerosis. A long-term follow-up

2023 - FRONTIERS IN NEUROLOGY

Zilli, Chiara; Scribani Rossi, Pietro; Di Stadio, Arianna; Fratino, Mariangela; Giuliani, Giada; Annecca, Rosanna; Russo, Gaetano; Di Piero, Vittorio; Altieri, Marta

Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis

2020 - FRONTIERS IN IMMUNOLOGY

Koudriavtseva, T.; Stefanile, A.; Fiorelli, M.; Lapucci, C.; Lorenzano, S.; Zannino, S.; Conti, L.; D'Agosto, G.; Pimpinelli, F.; Di Domenico, E. G.; Mandoj, C.; Giannarelli, D.; Donzelli, S.; Blandino, G.; Salvetti, M.; Inglese, M.

A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.

2020 - MULTIPLE SCLEROSIS

Fox, E; Lovett-Racke, Ae; Gormley, M; Liu, Y; Petracca, M; Cocozza, S; Shubin, R; Wray, S; Weiss, Ms; Bosco, Ja; Power, Sa; Mok, K; Inglese, M.

An overview of pregnancy-related issues in patients with multiple sclerosis

2015 - EUROPEAN JOURNAL OF NEUROLOGY

Pozzilli, Carlo; Pugliatti, M.